Deccan Healthcare has announced a change in its board composition. Ms. Samhitha Kandlakunta, an Independent Director, has completed her five-year term and will cease to hold the position at the close of business on September 23, 2025. This development reflects a routine transition on the board, as her full tenure has concluded. For shareholders, this means an update to the independent oversight on the company's governance and strategic decisions, a key aspect for maintaining robust corporate management.